Iris Pharma, which is headquartered in France, is an independent drug development service provider, totally dedicated to preclinical and clinical research in OPHTHALMOLOGY.
A focus on the eye allows Iris Pharma to remain at the forefront of this field and to deliver professional quality work. This helps pharmaceutical and biotechnology companies worldwide to pass their product through the testing and regulatory process in a rapid and cost-effective manner to market their drugs faster. Since 1989, Iris Pharma has helped bring more than 40 ocular drugs and medical devices to the American and European markets.
The company works in five complementary areas: preclinical studies (proof of concept, pilot, GLP regulatory studies and applied research) ; clinical trials (Phase I to IV) ; consulting service ; bioanalysis and preclinical formulation.
|
Company:
|
Iris Pharma | |
|
Headquarters Address:
|
Allee Hector Pintus | |
| La Gaude 06610 | ||
| France | ||
|
Main Telephone:
|
33493594959 | |
|
Website:
|
||
|
Type of Organization:
|
Private | |
|
Industry:
|
Research & Science | |
|
Key Executives:
|
CEO: Pierre-Paul Elena
|
|
|
Public Relations
|
||
|
Contact:
|
Katia Barcaroli | |
|
Email:
|
||
|
Customer Service
|
||
|
Contact:
|
Sophie Chiabaut | |
|
Email:
|



There are no comments yet